Insider: Dambkowski Carl Chief Medical Officer - Apogee Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 209,773 | 0 | 209,773 |
| Value | $17,671,277.52 | $0.00 | $17,671,277.52 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/04/2026 | DDS | 200 | Direct | COM | $73.26 | $14,652.00 | 209,773 |
| 03/04/2026 | DDS | 3,225 | Direct | COM | $70.33 | $226,814.25 | 212,048 |
| 03/04/2026 | DDS | 2,075 | Direct | COM | $71.98 | $149,358.50 | 209,973 |
| 02/04/2026 | DDS | 2,481 | Direct | COM | $64.88 | $160,967.28 | 214,167 |
| 02/04/2026 | DDS | 1,420 | Direct | COM | $65.83 | $93,478.60 | 212,747 |
| 02/04/2026 | DDS | 100 | Direct | COM | $67.88 | $6,788.00 | 211,348 |
| 02/04/2026 | DDS | 1,299 | Direct | COM | $66.85 | $86,838.15 | 211,448 |
| 02/04/2026 | DDS | 200 | Direct | COM | $68.94 | $13,788.00 | 211,148 |
| 01/07/2026 | DDS | 14,820 | Direct | COM | $77.90 | $1,154,478.00 | 213,449 |
| 01/07/2026 | DDS | 2,954 | Direct | COM | $77.13 | $227,842.02 | 228,269 |
| 01/07/2026 | DDS | 826 | Direct | COM | $79.04 | $65,287.04 | 212,623 |
| 01/07/2026 | DDS | 100 | Direct | COM | $80.06 | $8,006.00 | 212,523 |
| 12/04/2025 | DDS | 10,900 | Direct | COM | $75.00 | $817,500.00 | 271,108 |
| 10/01/2025 | DDS | 5,110 | Direct | COM | $39.80 | $203,378.00 | 284,733 |
| 09/03/2025 | DDS | 2,535 | Direct | COM | $37.82 | $95,873.70 | 233,738 |
| 09/03/2025 | DDS | 190 | Direct | COM | $38.55 | $7,324.50 | 233,548 |
| 08/06/2025 | DDS | 2,725 | Direct | COM | $37.78 | $102,950.50 | 236,273 |
| 07/02/2025 | DDS | 6,409 | Direct | COM | $44.77 | $286,930.93 | 242,679 |
| 07/02/2025 | DDS | 746 | Direct | COM | $46.26 | $34,509.96 | 238,998 |
| 07/02/2025 | DDS | 2,935 | Direct | COM | $45.49 | $133,513.15 | 239,744 |
| 06/04/2025 | DDS | 2,725 | Direct | COM | $36.96 | $100,716.00 | 241,723 |
| 05/07/2025 | DDS | 2,725 | Direct | COM | $35.75 | $97,418.75 | 244,448 |
| 04/02/2025 | DDS | 2,471 | Direct | COM | $35.56 | $87,868.76 | 248,562 |
| 04/02/2025 | DDS | 889 | Direct | COM | $37.59 | $33,417.51 | 247,173 |
| 04/02/2025 | DDS | 500 | Direct | COM | $37.03 | $18,515.00 | 248,062 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research